2022 ISPE Pharma 4.0™ and Annex 1 Conference

The 2022 ISPE Pharma 4.0™ and Annex 1 Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights and provide an outlook on the evolving landscape and future of Pharma 4.0™ supported Aseptic Manufacturing.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. This platform will showcase recent innovations and trends, and directly discuss practical challenges and solutions, from a technical, logistical, and regulatory perspective. The impact of upcoming regulations, in particular for Annex 1, will be integrated throughout the conference programme and panel discussions. Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference programme.

The key focus themes will include, but are not be limited to:

  • Pharma 4.0™ and the Contamination Control Strategy, Environmental Monitoring, and Rapid Microbiology Testing
  • How to maximise productivity by using closed systems and disposables
    • Annex 1 implementation within GXP compliance and cost containment
  • Quality 4.0 and Aseptic Processing: Predictive Data Analysis, Data Science, and Process Science
  • Industry Trends and Regulators’ Expectation
  • Pharma 4.0™ Roadmap for implementation
    • Lighthouse projects and Automation Islands to a Corporate Approach
    • Case Studies, Augmented Reality, Connected Health
  • Digital Maturity, Barriers and Success Factors
  • Modelling and Controlling of a Holistic Control Strategy
  • Pharma 4.0™ Enabling Technologies

Featured Speakers

What to Expect

Explore the Education Tracks

View Programme

Conference Highlights

ISPE Safety Precautions

Robust risk mitigation measures are being undertaken to instill public confidence in the safety of ISPE’s in-person events. In conjunction with the venues and vendors supporting our conference, we will follow health and safety measures issued at the time of the events by state and local authorities, with consideration of CDC guidance, to minimize the spread of COVID-19 and ensure the health and safety of our event participants.

Learn More

Program Committee

Jörg Zimmermann
Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.
Christian Woelbeling
Executive Industry Advisor
Richard Denk
Senior Consultant Aseptic Processing & Containment
Jean-Francois Duliere
Pharmaceutical Senior Expert, Vice Chair ISPE France Affiliate
Heike Roeder
Director, Lead Digital Quality, Risk Advisory Life Science
Thomas Zahel, PhD
Head of Innovation
Placeholder Person Graphic
Karine Peron
Head of Technology Management - EMEA
Merck Millipore
Josef Trapl
Head of MSci Innovation, GMS / Manufacturing Science
Takeda Pharmaceutical International AG
Yvonne Duckworth, PE
Director of Digital Technology
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
Wolfgang Winter
Director, Informatics Platform R&D
Agilent Technologies R&D Mktg GmbH & Co KG
Bernd Boedecker
Ex-EU GMP Inspector
GMP Freelance Consultant

Media Partners

IPQ media partner
The Medicine Maker media partner

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2021 ISPE Pharma 4.0™ and Annex 1 Conference.

Company Type